Helix BioPharma Corp.
Helix BioPharma Corp. (HBP.TO) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · HBP.TO · as of Jun 8, 2026
Key Statistics
Explore Helix BioPharma Corp. Data
hbp.to stock data · financialsFinancial Snapshot
Full FinancialsCompetitors & Peers
hbp.to competitorsHBP.TO
CRDL.TO
CYBN.NE
HLS.TO
JUSH.CN
LOVE.VStock Performance
Full HistoryAbout Helix BioPharma Corp.
Helix BioPharma Corp. operates as an immune-oncology company in Canada. It is developing L-DOS47 for the treatment of non-small cell lung cancer; and V-DOS47 that targets the vascular epithelial growt…
what is helix biopharma corp. · hbp.to stock overview · helix biopharma corp. company profile · who is helix biopharma corp. ceo · hbp.to TSX · helix biopharma corp. headquarters · helix biopharma corp. business segments
About Stock Overview & Key Data
Helix BioPharma Corp. (HBP.TO) is a Healthcare company in the Biotechnology industry, listed on TSX since Aug 13, 1996. As of the latest trading session, HBP.TO stock price is $1.58, with a market capitalization of $120.7M. The stock has returned +69.89% over the past 12 months and -33.33% year-to-date.
In fiscal year 2025, Helix BioPharma Corp. reported revenue of —. For detailed financial data including revenue history, earnings, and balance sheet — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Helix BioPharma Corp. (HBP.TO) stock price is $1.58. The stock is traded on TSX under the ticker symbol HBP.TO. The 52-week range is $0.84 – $5.40.